Real-world outcomes of anti-EGFR therapy in advanced non-small cell lung cancer EGFR mutated in Peru.

Marco Galvez-Nino,Rossana Ruiz,Katia Roque, Ofelia Coanqui,Natalia Valdivieso,Mivael Olivera,Apar Kishor Ganti,Luis Mas

Thoracic cancer（2023）

引用 0|浏览7

暂无评分

摘要

Our study demonstrates that erlotinib for advanced NSCLC harboring EGFR-activating mutations is effective even in patients usually excluded from clinical trial, like those previously exposed to one or more lines of chemotherapy or with brain metastases.

查看译文

关键词

EGFR,Latin American,lung cancer,real-world,survival

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要